Trial of the covid vaccine has been temporarily stopped in Russia. High vaccine demand and lack of dose has led to a sudden ban on trial of covid vaccine in new volunteers. On Thursday, a representative of the firm running the study said that it is a setback to stop Moscow's ambitious covid vaccine scheme. Let us tell you that 85% of the people in Russia did not see any side effect. Alexander Gintsburg, head of the Gamalaya Research Center, which created the vaccine, provided information on this Monday. Alexander said that side effects of the covid vaccine were seen in 15% of people. ' The third phase of Sputnik V trials are underway.

Russian vaccine trial in India to end next year. Russia's corona vaccine trial in India may end by the month of March. Hyderabad-based pharma company Dr Reddy, which is testing the Russian vaccine in India, has said that human trials of the third phase of the Russian vaccine are expected to be completed by March. Erez Israel, CEO of pharma company Dr. Reddy, said that registration for the mid-stage test of the Sputnik-V vaccine would begin in the next few weeks and the trial is expected to end by December.

Russia is joining hands with pharma company Dr Reddy Labs in India for the Phase Three trial of its Sputnik-V vaccine. The Drug Controller General of India (DCGI) has given permission for the clinical trial of the vaccine. Permission has also been given by the Indian Council of Medical Research (ICMR). Now the vaccine trials have been started in 12 government and private institutions across the country simultaneously. It includes five government and 6 private institutes, including GSVM Medical College.

Also Read:

Typhoon storm wreaks havoc in Vietnam, 35 people died

'Muslims have right to punish French', says Malaysia’s former PM Mahathir

' Important to stop Islamic terrorism': Trump on attacks in France

Trump officials end gray wolf protections across most of US